Rodger Novak, President

CRSP 698,007 shares

The estimated Net Worth of Rodger Novak is at least $10,072,241.01. Rodger Novak owns over 698,007 units of CRISPR Therapeutics AG stock worth over $10,072,241.01.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
30th November 2020CRSP - CRISPR Therapeutics AG50,000Exercise of derivative698,007$14.43$721,500.00$10,072,241.01
30th November 2020CRSP - CRISPR Therapeutics AG50,000Open or private sale648,007$125.00$6,250,000.00$81,000,875.00
30th November 2020CRSP - CRISPR Therapeutics AG50,000Exercise of derivative698,007$14.00$700,000.00$9,772,098.00
9th October 2020CRSP - CRISPR Therapeutics AG2,762Open or private sale648,007$100.00$276,200.00$64,800,700.00
9th October 2020CRSP - CRISPR Therapeutics AG2,762Exercise of derivative650,769$14.43$39,855.66$9,390,596.67
8th October 2020CRSP - CRISPR Therapeutics AG22,238Open or private sale648,007$100.00$2,223,800.00$64,800,700.00
8th October 2020CRSP - CRISPR Therapeutics AG22,238Exercise of derivative670,245$14.43$320,894.34$9,671,635.35
9th January 2019CRSP - CRISPR Therapeutics AG82,690Open or private sale1,048,007$35.01$2,894,976.90$36,690,725.07
8th January 2019CRSP - CRISPR Therapeutics AG17,310Open or private sale1,130,697$35.09$607,407.90$39,676,157.73
25th February 2019CRSP - CRISPR Therapeutics AG14,780Open or private sale1,033,227$40.00$591,232.52$41,331,353.10
4th March 2019CRSP - CRISPR Therapeutics AG3,500Open or private sale948,007$42.03$147,105.00$39,844,734.21
4th March 2019CRSP - CRISPR Therapeutics AG8,912Open or private sale951,507$41.29$367,948.85$39,284,774.36
4th March 2019CRSP - CRISPR Therapeutics AG64,115Open or private sale960,419$40.24$2,580,186.36$38,650,237.86
1st March 2019CRSP - CRISPR Therapeutics AG8,693Open or private sale1,024,534$40.01$347,796.50$40,990,375.90
10th June 2019CRSP - CRISPR Therapeutics AG50,000Open or private sale898,007$45.00$2,250,000.00$40,410,315.00
10th July 2019CRSP - CRISPR Therapeutics AG50,000Open or private sale848,007$50.00$2,500,065.00$42,401,452.41
19th November 2019CRSP - CRISPR Therapeutics AG33,618Open or private sale0$70.00$2,353,260.00$0.00
19th November 2019CRSP - CRISPR Therapeutics AG33,618Exercise of derivative33,618$14.43$485,107.74$485,107.74
19th May 2020CRSP - CRISPR Therapeutics AG50,000Open or private sale798,007$65.00$3,250,000.00$51,870,455.00
26th May 2020CRSP - CRISPR Therapeutics AG36,616Open or private sale748,007$70.27$2,573,006.32$52,562,451.89
22nd May 2020CRSP - CRISPR Therapeutics AG13,384Open or private sale784,623$70.01$937,013.84$54,931,456.23
23rd June 2020CRSP - CRISPR Therapeutics AG50,000Open or private sale698,007$75.00$3,750,000.00$52,350,525.00
1st July 2020CRSP - CRISPR Therapeutics AG50,000Open or private sale648,007$80.00$4,000,000.00$51,840,560.00
7th July 2020CRSP - CRISPR Therapeutics AG25,000Open or private sale648,007$90.00$2,250,000.00$58,320,630.00
7th July 2020CRSP - CRISPR Therapeutics AG19,414Exercise of derivative673,007$14.00$271,796.00$9,422,098.00
7th July 2020CRSP - CRISPR Therapeutics AG5,586Exercise of derivative653,593$1.81$10,110.66$1,183,003.33
19th August 2020CRSP - CRISPR Therapeutics AG25,000Open or private sale648,007$100.00$2,500,000.00$64,800,700.00
19th August 2020CRSP - CRISPR Therapeutics AG25,000Exercise of derivative673,007$14.00$350,000.00$9,422,098.00
1st September 2020CRSP - CRISPR Therapeutics AG3,840Open or private sale648,007$93.19$357,849.60$60,387,772.33
1st September 2020CRSP - CRISPR Therapeutics AG19,754Open or private sale651,847$92.59$1,829,022.86$60,354,513.73
1st September 2020CRSP - CRISPR Therapeutics AG1,406Open or private sale671,601$91.54$128,705.24$61,478,355.54
1st September 2020CRSP - CRISPR Therapeutics AG21,067Exercise of derivative673,007$14.43$303,996.81$9,711,491.01
1st September 2020CRSP - CRISPR Therapeutics AG3,933Exercise of derivative651,940$14.00$55,062.00$9,127,160.00